Cocrystal Pharma reduces stockholder meeting quorum to one-third

Cocrystal Pharma, Inc.

Board approved bylaw amendment on June 17, 2025 reducing quorum to one-third of voting power.
Quorum now requires one-third of outstanding shares entitled to vote, down from majority.
Amendment effective immediately; full text filed as Exhibit 3.1.
No other changes to bylaws or fiscal year were made.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.